Financhill
Sell
23

BFRI Quote, Financials, Valuation and Earnings

Last price:
$0.73
Seasonality move :
-41.3%
Day range:
$0.70 - $0.74
52-week range:
$0.54 - $1.87
Dividend yield:
0%
P/E ratio:
1.34x
P/S ratio:
0.18x
P/B ratio:
20.88x
Volume:
93.2K
Avg. volume:
117.5K
1-year change:
-28.71%
Market cap:
$8.4M
Revenue:
$37.3M
EPS (TTM):
-$1.82

Earnings Data

Next earnings date for BFRI
Mar 20
2026
Most recent earnings per share
-$0.62
Missed by $0.06
(Nov 12/2025)
Consensus Estimate
-$0.56
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BFRI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/20/2026 Q4 $15.5M -- -- $0.10 --
11/12/2025 Q3 $7M $7M -$0.62 -$0.56 -$0.06
08/13/2025 Q2 $8.3M $9M -$0.57 -$0.39 -$0.18
05/14/2025 Q1 $10.6M $8.6M -$0.47 -$0.29 -$0.18
12/31/2024 Q4 $14.5M $12.6M -$0.16 -$0.07 -$0.09
09/30/2024 Q3 $10M $9M -$0.98 -$0.94 -$0.04
06/30/2024 Q2 $8.2M $7.8M -$0.05 -$0.35 $0.30
03/31/2024 Q1 $10.9M $7.9M -$2.88 -$0.71 -$2.17
12/31/2023 Q4 $10.6M $10.6M $4.55 -$0.85 $5.40
09/30/2023 Q3 -- -- -$4.64 -$3.34 -$1.30
08/11/2023 Q2 -- -- -$7.23 -$4.08 -$3.15
05/12/2023 Q1 -- -- -$5.60 -$3.40 -$2.20
12/31/2022 Q4 -- -- -$2.09 -$2.20 $0.11
11/30/2022 Q3 -- -- -$2.26 -$5.80 $3.54
08/12/2022 Q2 -- -- -$0.90 -$6.80 $5.90
05/13/2022 Q1 -- -- $6.40 -$3.20 $9.60
03/31/2022 Q4 -- -- -$25.80 -- --
11/30/2021 Q3 -- -- -$29.11 -- --
06/30/2021 Q2 -- -- -$6.31 -- --
03/31/2021 Q1 -- -- -$6.09 -- --
12/31/2020 Q4 -- -- -$0.32 -- --
09/30/2020 Q3 -- -- -$5.15 -- --

Biofrontera, Inc. Earnings Questions

  • How Much did Biofrontera, Inc. Generate in Revenue Last Quarter?

    Biofrontera, Inc. reported $7M worth of top line sales in its most recent quarter.

  • Did Biofrontera, Inc. Beat Earnings Last Quarter?

    Biofrontera, Inc. announced earnings per share of -$0.62 which represents a miss of analyst forecast a -$0.56 per share.

  • Is Biofrontera, Inc. Profitable?

    Biofrontera, Inc. reported $4.9M that represents $0.46 per share over the last quarter.

  • What is the Analyst Consensus for Biofrontera, Inc. EPS Next Year?

    Biofrontera, Inc.'s earnings are forecast to decrease from -$3.22 per share to -$2.98 per share next year representing a decrease of -53.1%.

  • When is Biofrontera, Inc.'s Earnings Date?

    Biofrontera, Inc.'s next earnings date is March 20, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock